Outlook jumps 24% to $1.64 after FDA approves wet AMD treatment
Outlook jumps 24% to $1.64 after FDA approves wet AMD treatment
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.